Retrieve available abstracts of 54 articles: HTML format
Single Articles
June 2025
KRASNIQI L, Skovbo JS, Hallas PJ, Brandes PA, et al Impact of statin treatment on postoperative atrial fibrillation in surgical
aortic valve replacement.
Am Heart J. 2025 Jun 13:S0002-8703(25)00194-2. doi: 10.1016/j.ahj.2025. PubMedAbstract available
April 2025
JIANG Z, Chang S, Tao L, Luo J, et al The randomized controlled trial to compare temporary permanent pacemaker versus
temporary pacemaker in patients with conduction block after transcatheter aortic
valve replacement: rationale and design of the RECOVER trial: Randomized trial
for Tempora
Am Heart J. 2025 Apr 19:S0002-8703(25)00135-8. doi: 10.1016/j.ahj.2025. PubMedAbstract available
GRBAC AJ, Lee MGY, Chye D, Zhou JY, et al MANAGEMENT OF ASYMPTOMATIC SEVERE AORTIC STENOSIS: A CRITICAL REVIEW OF
GUIDELINES AND CLINICAL OUTCOMES.
Am Heart J. 2025 Apr 15:S0002-8703(25)00128-0. doi: 10.1016/j.ahj.2025. PubMedAbstract available
HORN N, Gartner L, Rastan AJ, Andrasi TB, et al Effects of a preoperative psychological expectation-focused intervention in
patients undergoing valvular surgery - the randomized controlled ValvEx (valve
patients' expectations) study.
Am Heart J. 2025;282:156-169. PubMedAbstract available
February 2025
ANDO T, Nazif T, Briasoulis A, Afonso L, et al Clinical Outcomes of Direct Oral Anticoagulant Versus Warfarin After
Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry.
Am Heart J. 2025 Feb 26:S0002-8703(25)00057-2. doi: 10.1016/j.ahj.2025. PubMedAbstract available
LEENING MJG, Khan CF, Zhu F, Singh SS, et al Lipoprotein(a) immunoassays and their associations with coronary artery
calcification and aortic valve calcification.
Am Heart J. 2025 Feb 18:S0002-8703(25)00040-7. doi: 10.1016/j.ahj.2025. PubMedAbstract available
JORGENSEN TH, Thyregod HGH, Savontaus M, Bleie O, et al Transcatheter or Surgical Aortic Valve Replacement in patients with Severe Aortic
Stenosis Aged 70 Years or Younger - a NOTION-2 sub-study.
Am Heart J. 2025 Feb 12:S0002-8703(25)00034-1. doi: 10.1016/j.ahj.2025. PubMedAbstract available
NAKASE M, Tomii D, Maznyczka A, Heg D, et al Five-year outcomes with self-expanding versus balloon-expandable TAVI in patients
with left ventricular systolic dysfunction.
Am Heart J. 2025;280:18-29. PubMedAbstract available
January 2025
BALDI C, Maio MD, Esposito L, Bellino M, et al How the COAPT trial affected the selection of patients with secondary mitral
regurgitation undergoing transcatheter edge-to-edge repair: insights from the
GIOTTO Registry.
Am Heart J. 2025 Jan 27:S0002-8703(25)00011-0. doi: 10.1016/j.ahj.2025. PubMedAbstract available
SHECHTER A, Gupta A, Kaewkes D, Taheri H, et al Implications of an Off-Hours Setting in Patients Undergoing Transcatheter
Edge-to-Edge Repair for Mitral Regurgitation.
Am Heart J. 2025 Jan 2:S0002-8703(24)00341-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
December 2024
AARTS HM, Hemelrijk KI, Broeze GM, van Ginkel DJ, et al Deferral of routine percutaneous coronary intervention in patients undergoing
transcatheter aortic valve implantation: rationale and design of the PRO-TAVI
trial: the PRO-TAVI trial: rationale and design.
Am Heart J. 2024 Dec 12:S0002-8703(24)00332-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
November 2024
REDDY KP, Shultz K, Eberly LA, Khatana SAM, et al Contribution margins and utilization of transcatheter aortic valve replacement
versus surgical aortic valve replacement in the Medicare population.
Am Heart J. 2024 Nov 27:S0002-8703(24)00302-8. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ABRAHAM B, Suppah M, Farina J, Botros M, et al Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after
Transcatheter Aortic Valve Replacement.
Am Heart J. 2024 Nov 12:S0002-8703(24)00295-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
IANNOPOLLO G, Cocco M, Leone A, Sacca S, et al TRanscatheter Aortic-Valve Implantation with or without on-site Cardiac Surgery:
the TRACS trial: TAVI in centers without on-site cardiac surgery.
Am Heart J. 2024 Nov 4:S0002-8703(24)00281-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
October 2024
THURAIAIYAH J, Jorgensen TH, Jensen JM, Fuchs A, et al Prospective study on the impact of different anti-thrombotic therapies on
subclinical leaflet thickening and its temporal dynamics in transcatheter aortic
valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT.
Am Heart J. 2024 Oct 5:S0002-8703(24)00264-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
August 2024
SOH CH, Wright L, Baumann A, Seidel B, et al Use of artificial intelligence-guided echocardiography to detect cardiac
dysfunction and heart valve disease in rural and remote areas: Rationale and
design of the AGILE-echo trial.
Am Heart J. 2024;277:11-19. PubMedAbstract available
DISMORR M, Granbom-Koski M, Ellfors E, Ruck A, et al Sex differences and long-term clinical outcomes after transcatheter aortic valve
replacement: a SWEDEHEART study.
Am Heart J. 2024 Aug 9:S0002-8703(24)00185-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
STAHLI BE, Linke A, Westermann D, Van Mieghem NM, et al A Randomized Comparison of the Treatment Sequence of Percutaneous Coronary
Intervention and Transcatheter Aortic Valve Implantation: Rationale and Design of
the TAVI PCI Trial.
Am Heart J. 2024 Aug 7:S0002-8703(24)00184-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
TERKELSEN CJ, Thim T, Freeman P, Dahl JS, et al Randomized comparison of TAVI valves: The Compare-TAVI trial.
Am Heart J. 2024;274:84-94. PubMedAbstract available
July 2024
BUTT JH, Yafasova A, Thein D, Begun X, et al Burden of Hospitalization During the First Year Following Transcatheter and
Surgical Aortic Valve Replacement.
Am Heart J. 2024 Jul 29:S0002-8703(24)00180-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ELLFORS E, Dismorr M, Ruck A, Settergren M, et al Predicted prosthesis-patient mismatch and long-term clinical outcomes after
transcatheter aortic valve replacement: a SWEDEHEART study.
Am Heart J. 2024 Jul 18:S0002-8703(24)00175-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
PERSITS I, Mirzai S, Sarnaik KS, Volk MC, et al Sarcopenia and Frailty in Patients Undergoing Transcatheter Aortic Valve
Replacement.
Am Heart J. 2024 Jul 18:S0002-8703(24)00173-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
June 2024
ABOU-KARAM R, Tanguturi V, Cheng F, Elmariah S, et al Trial Designs A44002PZS Electronic Physician Notification to Facilitate the
Recognition and Management of Severe Aortic Stenosis: Rationale, design, and
methods of the randomized controlled DETECT AS Trial.
Am Heart J. 2024 Jun 29:S0002-8703(24)00163-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
MIYAWAKI N, Ishizu K, Shirai S, Miyahara K, et al Impact of the Clinical Frailty Scale on Long-term Outcomes After Transcatheter
Aortic Valve Implantation.
Am Heart J. 2024 Jun 12:S0002-8703(24)00139-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
BRUNO F, Rampone JM, Islas F, Gorla R, et al Echocardiographic and clinical features of patients developing prosthesis-patient
mismatch after TAVR: insights from the Recovery TAVR registry.
Am Heart J. 2024 Jun 3:S0002-8703(24)00137-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
May 2024
LUPU L, Haberman D, Chitturi KR, Wermers JP, et al Overview of 2024 FDA Advisory Panel Meeting on the TriClip Transcatheter
Tricuspid Valve Repair System.
Am Heart J. 2024 May 29:S0002-8703(24)00126-1. doi: 10.1016/j.ahj.2024. PubMedAbstract available
RICHARDSON C, Gilbert T, Aslam S, Brookes CL, et al Rationale and design of the Early valve replacement in severe ASYmptomatic Aortic
Stenosis Trial.
Am Heart J. 2024 May 29:S0002-8703(24)00128-5. doi: 10.1016/j.ahj.2024. PubMedAbstract available
GUO Y, Liu X, Li R, Ng S, et al Comparison of Down Sizing Strategy (HANGZHOU Solution) and Standard Annulus
Sizing Strategy in type 0 bicuspid aortic stenosis patients undergoing
transcatheter aortic valve replacement: Rationale and design of a randomized
clinical trial.
Am Heart J. 2024 May 1:S0002-8703(24)00098-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
April 2024
ETIWY M, Flannery LD, Li SX, Morrison FJ, et al Examining Lack of Referrals to Heart Valve Specialists as Mechanisms of Potential
Underutilization of Aortic Valve Replacement.
Am Heart J. 2024 Apr 13:S0002-8703(24)00093-0. doi: 10.1016/j.ahj.2024. PubMedAbstract available
March 2024
KIM M, Ahn JM, Kang DY, Kim MJ, et al Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus
and cerebral thromboembolism after TAVR: A prespecified analysis of randomized
ADAPT-TAVR trial.
Am Heart J. 2024;269:167-178. PubMedAbstract available
February 2024
ZHANG J, Kong XQ, Gao XF, Chen J, et al Transfemoral transcatheter aortic valve replacement with VitaFlow(TM) valve for
pure native aortic regurgitation in patients with high surgical risk: Rationale
and design of a prospective, multicenter, and randomized SEASON-AR trial.
Am Heart J. 2024 Feb 25:S0002-8703(24)00049-8. doi: 10.1016/j.ahj.2024. PubMedAbstract available
PREGOWSKI J, Pracon R, Mioduszewska A, Skowronski J, et al Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal
Interventions: Design and rationale of the STOP CLOT Trial.
Am Heart J. 2024 Feb 22:S0002-8703(24)00043-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided
Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve
Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic
Valve Stenosis and M
Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
January 2024
JAMMOUL N, Dupasquier V, Akodad M, Meunier PA, et al Long-term follow-up of balloon-expandable valves according to the implantation
strategy: insight from the DIRECTAVI trial.
Am Heart J. 2024 Jan 20:S0002-8703(24)00014-0. doi: 10.1016/j.ahj.2024. PubMedAbstract available
December 2023
HEGEMAN RRMJJ, van Ginkel DJ, Langle S, Timmers L, et al Preoperative CT-imaging with patient-specific computer simulation in
transcatheter aortic valve implantation: Design and rationale of the GUIDE-TAVI
trial.
Am Heart J. 2023 Dec 30:S0002-8703(23)00360-5. doi: 10.1016/j.ahj.2023. PubMedAbstract available
GENEREUX P, Schwartz A, Oldemeyer B, Cohen DJ, et al Design and Rationale of the Evaluation of Transcatheter Aortic Valve Replacement
Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis:
The EARLY TAVR Trial.
Am Heart J. 2023 Dec 4:S0002-8703(23)00326-5. doi: 10.1016/j.ahj.2023. PubMedAbstract available
SEVERINSEN T, Thune JJ, Gudmundsdottir HL, Vissing CR, et al Angiotensin receptor blockers in patients with hypertrophic cardiomyopathy: A
comparison of VANISH and INHERIT randomized trials.
Am Heart J. 2023;266:198-200. PubMedAbstract available
November 2023
KIM M, Choi JH, Kim HK, Kim HL, et al Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in
Aortic Valve Disease.
Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al High-risk admission prior to transcatheter aortic valve replacement and
subsequent outcomes: Preceding events and outcomes after TAVR.
Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023. PubMedAbstract available
October 2023
BARON SJ, Ryan MP, Chikermane SG, Thompson C, et al Long-Term Risk of Reintervention after Transcatheter Aortic Valve Replacement.
Am Heart J. 2023 Oct 21:S0002-8703(23)00296-X. doi: 10.1016/j.ahj.2023. PubMedAbstract available
August 2023
DODGSON CAS, Beitnes JO, Klove SF, Herstad J, et al An investigator-sponsored pragmatic randomised controlled trial of
AntiCoagulation versus AcetylSalicylic Acid after Transcatheter Aortic Valve
Implantation - Rationale and design of ACASA-TAVI: Blinded outcome adjudication.
Am Heart J. 2023 Aug 25:S0002-8703(23)00208-9. doi: 10.1016/j.ahj.2023. PubMedAbstract available
L'HOYES W, Robyns T, Moura-Fereira S, De Meester P, et al Effectiveness of the Risk Stratification Proposed by the 2022 European Heart
Rhythm Association Expert Consensus Statement on Arrhythmic Mitral Valve
Prolapse.
Am Heart J. 2023 Aug 16:S0002-8703(23)00201-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
SOLOMON MD, Tabada G, Sung SH, Allen A, et al Physician Assessment of Aortic Stenosis Severity, Quantitative Parameters, and
Long-Term Outcomes: Results from the KP-VALVE Project.
Am Heart J. 2023 Aug 6:S0002-8703(23)00182-5. doi: 10.1016/j.ahj.2023. PubMedAbstract available
July 2023
KALMUCKI P, Lipiecki J, Witte KK, Goldberg SL, et al Percutaneous mitral annuloplasty with the Carillon device: outcomes in
proportionate and disproportionate functional mitral regurgitation.
Am Heart J. 2023 Jul 27:S0002-8703(23)00181-3. doi: 10.1016/j.ahj.2023. PubMedAbstract available
June 2023
SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of
Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic
Valve Implantation (The IMPACTavi registry): Design and Rationale.
Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023. PubMedAbstract available
KIRMANI S, Woodard PK, Shi L, Hamza TH, et al Cardiac Imaging and Biomarkers for Assessing Myocardial Fibrosis in Children with
Hypertrophic Cardiomyopathy.
Am Heart J. 2023 Jun 12:S0002-8703(23)00160-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
SHECHTER A, Koren O, Skaf S, Makar M, et al Transcatheter Edge-to-Edge Repair for Chronic Functional Mitral Regurgitation in
Patients with Very Severe Left Ventricular Dysfunction.
Am Heart J. 2023 Jun 3:S0002-8703(23)00138-2. doi: 10.1016/j.ahj.2023. PubMedAbstract available
MEWTON N, Donal E, Picard F, Derimay F, et al Prognostic impact of precipitated cardiac decompensation in symptomatic heart
failure with reduced ejection fraction and severe secondary mitral regurgitation.
Am Heart J. 2023 Jun 2:S0002-8703(23)00137-0. doi: 10.1016/j.ahj.2023. PubMedAbstract available
RYMER JA, Sun JL, Chiswell K, Cohen D, et al Variation in resource utilization and mortality among patients with varying MR
type and severity.
Am Heart J. 2023;260:44-57. PubMedAbstract available
May 2023
BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al Patient Characteristics and Long-term Outcomes in Patients Undergoing
Transcatheter Aortic Valve Implantation in a Failed Surgical Prosthesis versus in
a Native Valve: A Danish nationwide study.
Am Heart J. 2023 May 11:S0002-8703(23)00118-7. doi: 10.1016/j.ahj.2023. PubMedAbstract available
April 2023
LAURIDSEN MD, Valentin JB, Strange JE, Jacobsen PA, et al Mortality in patients with chronic obstructive pulmonary disorder undergoing
transcatheter aortic valve replacement: The importance of chronic obstructive
pulmonary disease exacerbation.
Am Heart J. 2023;262:100-109. PubMedAbstract available
COISNE A, Aghezzaf S, Butruille L, Woitrain E, et al Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of
Aortic Stenosis.
Am Heart J. 2023 Apr 24:S0002-8703(23)00099-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
DEMIREL C, Tomii D, Heg D, Okuno T, et al Incidental detection of malignancy during pre-procedural workup for transcatheter
aortic valve implantation: a longitudinal cohort study.
Am Heart J. 2023 Apr 1:S0002-8703(23)00072-8. doi: 10.1016/j.ahj.2023. PubMedAbstract available
October 2021
ANANTHAKRISHNA R, Lee SL, Foote J, Sallustio BC, et al Randomized controlled trial of perhexiline on regression of left ventricular
hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM
trial).
Am Heart J. 2021;240:101-113. PubMedAbstract available